We are live on
!
Find out more
MS
Marshall & Sullivan Portfolio holdings
AUM
$216M
1-Year Est. Return
12.97%
This Fund
S&P 500
This Quarter
Est. Return
+4.68%
1 Year Est. Return
+12.97%
3 Year Est. Return
+82%
5 Year Est. Return
+98.09%
10 Year Est. Return
+292.06%
AUM
$142M
AUM Growth
+$5.56M
(+4.1%)
Cap. Flow
-$1.78M
Cap. Flow
% of AUM
-1.26%
Top 10 Holdings %
Top 10 Hldgs %
48.38%
Holding
45
New
2
Increased
15
Reduced
17
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$631K |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$374K |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$357K |
| 4 |
State Street SPDR S&P Bank ETF
KBE
|
+$356K |
| 5 |
Procter & Gamble
PG
|
+$204K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.81M |
| 2 |
Church & Dwight Co
CHD
|
+$426K |
| 3 |
Mastercard
MA
|
+$378K |
| 4 |
Expeditors International
EXPD
|
+$228K |
| 5 |
Chevron
CVX
|
+$216K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.89% |
| 2 | Consumer Discretionary | 11.39% |
| 3 | Technology | 10.09% |
| 4 | Consumer Staples | 9.31% |
| 5 | Financials | 7.48% |
Similar funds
DSN
ICM
FFAM
NWM
LA
APC
WTFG
SNWA
Marshall & Sullivan's Q2 2019 Portfolio in Review
As of Q2 2019, Marshall & Sullivan held 45 positions worth $142M, up 4.1% from $136M the previous quarter. Its ten largest holdings account for 48% of the portfolio.
Marshall & Sullivan's Q2 2019 filing shows 2 new, 15 increased, 17 reduced and 4 closed positions. Its largest new stake was Procter & Gamble: 1,913 shares worth $210K. The largest sale was Celgene Corp, an estimated $1.81M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 24% a quarter earlier, followed by Consumer Discretionary and Technology.
- Marshall & Sullivan's largest Q2 2019 buy was Procter & Gamble: 1,913 shares worth $210K.
- Marshall & Sullivan added most to Fortive in Q2 2019, an estimated $631K increase.
- Marshall & Sullivan's biggest Q2 2019 reduction was Church & Dwight Co, cutting an estimated $426K.
- Marshall & Sullivan fully exited Celgene Corp in Q2 2019, selling an estimated $1.81M.
- Marshall & Sullivan's ten largest holdings make up 48% of its $142M portfolio in Q2 2019.
- Marshall & Sullivan opened 2 new positions and closed 4 in Q2 2019.
- Marshall & Sullivan's portfolio value rose 4.1% quarter-over-quarter to $142M.
Based on Marshall & Sullivan's 13F filing for Q2 2019, filed 5 Aug 2019.